<DOC>
	<DOCNO>NCT01315236</DOCNO>
	<brief_summary>The purpose study evaluate efficacy , safety tolerability 84 day daily dose 590 mg LAI versus placebo patient recalcitrant NTM lung disease .</brief_summary>
	<brief_title>Arikayce Nontuberculous Mycobacteria</brief_title>
	<detailed_description />
	<mesh_term>Mycobacterium Infections</mesh_term>
	<mesh_term>Mycobacterium Infections , Nontuberculous</mesh_term>
	<mesh_term>Amikacin</mesh_term>
	<criteria>Key 1 . Diagnosis pulmonary nontuberculous mycobacterial lung disease accordance 2007 ATS/IDSA criterion evidence nodular bronchiectasis and/or cavitary disease chest compute tomography ( CT ) . 2 . History chronic infection either Mycobacterium avium complex Mycobacterium abscessus mixed infection specie ( define least 2 documented positive culture prior 2 year , least one obtain 6 month prior screen ) . 3 . Positive sputum culture obtain screen visit either Mycobacterium avium complex Mycobacterium abscessus mixed infection one dominant specie . 4 . Receiving ATS/IDSA guidelinesbased treatment regimen define : adherent multidrug regimen least 6 month prior screen persistently positive mycobacterial culture . 5 . Ability produce least 3 mL sputum willing undergo induction produce least 3 mL sputum clinical evaluation . 6 . Female childbearing potential agrees practice acceptable method birth control ( e.g. , abstinence , hormonal barrier method , partner sterilization , IUD ) . Key 1 . Forced Expiratory Volume 1 second ( FEV1 ) &lt; 30 % predict Screening . 2 . Presence clinically significant cardiac disease determine Investigator . The QTc criterion Exclusion QTc &gt; 450 msec male QTc &gt; 470 msec female . 3 . Subjects hemoptysis ≥60 mL 24 hour period within 4 week prior screen . 4 . Active pulmonary malignancy ( primary metastatic ) malignancy require chemotherapy radiation therapy within one year prior screen anticipate study period . 5 . Active allergic bronchopulmonary mycosis condition require systemic steroid dose ≥ equivalent 10 mg/day prednisone within 3 month prior screen anticipate study period . 6 . Pulmonary tuberculosis require treatment treat within 2 year prior screen . 7 . History lung transplantation . 8 . Hypersensitivity aminoglycosides . 9 . Any change chronic NTM multidrug regimen within 28 day prior Study Day 1 . 10 . Evidence biliary cirrhosis portal hypertension . 11 . History daily , continuous oxygen supplementation . 12 . Smoking tobacco substance within 6 month prior screen anticipate inability refrain smoking throughout study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>